CF

Chuck Farkas

North America, Massachusetts, United States, Boston

Description

Charles Farkas became an Advisory Partner at Bain & Company in July, 2015. Prior to that he was a Senior Partner in Bain & Company’s Boston ...

Investor Profile

Chuck Farkas has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Private Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Genetics, Health Diagnostics.

Stage Focus

  • Private Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Chuck Farkas frequently co-invest with?

Bunker Hill Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Harbor Light Capital Partners
North America, New Hampshire, United States, Keene
Co-Investments: 1
First Analysis
North America, Illinois, United States, Chicago
Co-Investments: 1
Adler & Co.
North America, Colorado, United States, Westminster
Co-Investments: 1

What are some of recent deals done by Chuck Farkas?

Courtagen Life Sciences

Woburn, Massachusetts, United States

Courtagen Life Sciences is a biotech company that provides proteomic and genomic products and services to the life sciences industry.

BiotechnologyGeneticsHealth DiagnosticsLife Science
Private EquityJul 1, 2015
Amount Raised: $20,000,000